Myoderm Selects Tracie DiPasquale To Lead CentralSource

Share Article

She’ll oversee Myoderm’s revolutionary turnkey sourcing service.

Myoderm, a global leader in sourcing commercial drugs for clinical trials, is pleased to announce that Tracie DiPasquale has joined the company as Director, CentralSource. She will work out of Myoderm’s US office.

Myoderm is fortunate to have someone with Tracie’s background and qualifications to direct CentralSource, the company’s turnkey sourcing, distribution, and management service that supplies individual sites directly on an as-needed basis. For over a decade, she managed business development efforts and implemented supply chain strategies for leading pharmaceutical firms, including Pfizer and Almac. Her diversified experience with both large and small pharmaceutical companies gives her the insight and flexibility to exceed clients’ needs.

A graduate of the University of Pittsburgh, with a B.Sc. degree in Natural Sciences and a minor in Biology, Tracie offers Myoderm customers a unique understanding of global clinical site drug supply management and oversight issues.

Mike Cohen, Managing Director of Myoderm, says, “Tracie’s experience from both the service and client sides gives her an invaluable perspective on sourcing issues and makes her a superb advocate for Myoderm clients.”

About Myoderm
Myoderm is a leader in the sourcing, distribution, and management of commercial pharmaceutical products and supplies for clinical trials and biosimilar research. The company’s clients span the globe and include biotech, CROs, clinical trial packagers, and the majority of the world’s top10 pharmaceutical companies. With its deep expertise, customized solutions, and commitment to personalized service, Myoderm provides the optimal drug supply solution for global clinical studies.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maryanne Walsh
Myoderm USA
+1.610.233.3300
Email >
Follow us on
Visit website